Literature DB >> 21508077

Cardiac rehabilitation outcomes in a conventional versus telemedicine-based programme.

Lance C Dalleck1, Lindsey K Schmidt, Richard Lueker.   

Abstract

We studied patients who were eligible for phase II cardiac rehabilitation. Rehabilitation was delivered either conventionally or by telemedicine using videoconferencing. There were 226 participants: 173 at the conventional site and 53 at the telemedicine site. At baseline, blood pressure, anthropometric measurements, lipid profiles, activity levels, dietary intake and behaviours were assessed. Assessments at baseline were repeated after 12 weeks, at the end of the rehabilitation programme. There were no significant differences (P > 0.05) in the change from baseline to post-programme values between the conventional and the telemedicine groups. The results show the suitability of telemedicine for delivering cardiac rehabilitation for risk factor modification and exercise monitoring to patients who otherwise would not have access to it.

Entities:  

Mesh:

Year:  2011        PMID: 21508077     DOI: 10.1258/jtt.2010.100407

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  15 in total

1.  [Telemedicine during cardiac rehabilitation after acute myocardial infarction].

Authors:  B Schwaab
Journal:  Herz       Date:  2012-02       Impact factor: 1.443

Review 2.  Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy.

Authors:  Thomas W Storer; Renee Miciek; Thomas G Travison
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

Review 3.  Cardiac Rehabilitation for Women: A Systematic Review of Barriers and Solutions.

Authors:  Marta Supervía; Jose R Medina-Inojosa; Colin Yeung; Francisco Lopez-Jimenez; Ray W Squires; Carmen M Pérez-Terzic; LaPrincess C Brewer; Shawn E Leth; Randal J Thomas
Journal:  Mayo Clin Proc       Date:  2017-03-13       Impact factor: 7.616

4.  Exercise Telemonitoring and Telerehabilitation Compared with Traditional Cardiac and Pulmonary Rehabilitation: A Systematic Review and Meta-Analysis.

Authors:  Christen Chan; Cristiane Yamabayashi; Nafeez Syed; Ashley Kirkham; Pat G Camp
Journal:  Physiother Can       Date:  2016       Impact factor: 1.037

5.  The relationship between exercise dose and health-related quality of life with a phase III cardiac rehabilitation program.

Authors:  Borja Del Pozo-Cruz; Graeme Carrick-Ranson; Stacey Reading; Paul Nolan; Lance C Dalleck
Journal:  Qual Life Res       Date:  2018-01-19       Impact factor: 4.147

6.  A Clinical Decision Support System for Remote Monitoring of Cardiovascular Disease Patients: A Clinical Study Protocol.

Authors:  Filipa Ventura; Pedro Sousa; Maria Anjos Dixe; Paulo Ferreira; Ricardo Martinho; Sara Simões Dias; João Morais; Lino M Gonçalves
Journal:  Front Public Health       Date:  2022-05-09

7.  Motivating patients in cardiac rehabilitation programs: A multicenter randomized controlled trial.

Authors:  Helle Spindler; Malene Hollingdal; Jens Refsgaard; Birthe Dinesen
Journal:  Int J Telerehabil       Date:  2021-06-22

8.  Effect of continuous care model on lifestyle of patients with myocardial infarction.

Authors:  Zahra Molazem; Soheila Rezaei; Zinat Mohebbi; Mohammad-Ali Ostovan; Sareh Keshavarzi
Journal:  ARYA Atheroscler       Date:  2013-05

9.  "The Heart Game": Using Gamification as Part of a Telerehabilitation Program for Heart Patients.

Authors:  Marcus Dithmer; Jack Ord Rasmussen; Erik Grönvall; Helle Spindler; John Hansen; Gitte Nielsen; Stine Bæk Sørensen; Birthe Dinesen
Journal:  Games Health J       Date:  2015-11-18

Review 10.  Behavior Change Techniques in Physical Activity eHealth Interventions for People With Cardiovascular Disease: Systematic Review.

Authors:  Orlaith Mairead Duff; Deirdre Mj Walsh; Bróna A Furlong; Noel E O'Connor; Kieran A Moran; Catherine B Woods
Journal:  J Med Internet Res       Date:  2017-08-02       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.